Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPI-62 for hypercortisolism related to benign adrenal tumor
2022-000748-32Phase 2Terminated
- Sponsor
- Sparrow Pharmaceuticals
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of clofutriben in Cushing's syndrome, sponsored by Sparrow Pharmaceuticals. Started Jun 2022; status: terminated.
02
Drugs
clofutriben
03
Conditions
Cushing's syndrome
Beyond the preview
Go deeper on 2022-000748-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-000748-32.